StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Valeant Pharma (VRX) said still discussing possible sale of Bausch + Lomb - Fox News
April 8, 2016 12:30 PM
Valeant Pharma (NYSE: VRX) said still discussing possible sale of Bausch + Lomb, according to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Mergers and Acquisitions
Rumors
Spinoffs
Trader Talk
Next Articles
Valeant (VRX) Divestitures 'Unlikely' Near-Term, Says Rodman & Renshaw
April 11, 2016 8:21 AM
Streetinsider.com's Hot Lunchtime Reads 4/8: (CLVS) (VRX) (TSLA) (SGYP)
April 8, 2016 12:09 PM
Letter of Consent is Positive Development for Valeant (VRX); Ratings May Still be Cut - Moody's
April 8, 2016 11:57 AM
Valeant (VRX) Derm NRx Down 6% Week-Over-Week - RBC Capital
April 8, 2016 10:21 AM
Ackman Shoots Down Idea of Valeant (VRX) Unloading Bausch & Lomb
April 8, 2016 6:29 AM
UPDATE: Valeant Pharma (VRX) Said Actively Discussing Sale of Bausch + Lomb Unit
April 7, 2016 3:40 PM
